These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6203610)

  • 1. Retrograde transport of dopamine beta-hydroxylase antibodies in sympathetic neurons: effects of drugs modifying noradrenergic transmission.
    Lees GJ; Horsburgh RJ
    Brain Res; 1984 Jun; 301(2):281-6. PubMed ID: 6203610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phentolamine increases neuronal binding and retrograde transport of dopamine beta-hydroxylase antibodies.
    Lees GJ; Geffen LB; Rush RA
    Neurosci Lett; 1981 Mar; 22(2):115-8. PubMed ID: 6164961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of nerve activity on transport of nerve growth factor and dopamine beta-hydroxylase antibodies in sympathetic neurones.
    Lees G; Chubb I; Freeman C; Geffen L; Rush R
    Brain Res; 1981 Jun; 214(1):186-9. PubMed ID: 6165443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the retrograde axonal transport of dopamine-beta-hydroxylase antibodies by the calcium ionophore A23187.
    Lees GJ
    Brain Res; 1985 Oct; 345(1):62-7. PubMed ID: 2415213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific uptake and retrograde flow of antibody to dopamine-beta-hydroxylase by central nervous system noradrenergic neurons in vivo.
    Silver MA; Jacobowitz DM
    Brain Res; 1979 May; 167(1):65-75. PubMed ID: 88246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective uptake and retrograde axonal transport of dopamine-beta-hydroxylase antibodies in peripheral adrenergic neurons.
    Fillenz M; Gagnon C; Stoeckel K; Thoenen H
    Brain Res; 1976 Sep; 114(2):293-303. PubMed ID: 61057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrograde axonal transport of dopamine beta hydroxylase antibodies by neurons in the trigeminal ganglion.
    Reynolds AJ; Kaasinen SK; Hendry IA
    Neurochem Res; 2005; 30(6-7):703-12. PubMed ID: 16187207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presence and axonal transport of cholinoceptor, but not adrenoceptor sites on a cat noradrenergic neurone.
    Alonso FG; Ceña V; García AG; Kirpekar SM; Sánchez-García P
    J Physiol; 1982 Dec; 333():595-618. PubMed ID: 6189990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of nerve terminal events in vivo effecting retrograde transport of vesicles containing neurotrophins or synaptic vesicle components.
    Weible MW; Ozsarac N; Grimes ML; Hendry IA
    J Neurosci Res; 2004 Mar; 75(6):771-81. PubMed ID: 14994338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The regulation of the retrograde axonal transport of (125)I-beta nerve growth factor is independent of calcium.
    Bartlett SE; Reynolds AJ; Hendry IA
    Brain Res; 1999 Aug; 837(1-2):8-14. PubMed ID: 10433982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune lesions of central noradrenergic neurons produced by antibodies to dopamine-beta-hydroxylase.
    Costa M; Geffen LB; Rush RA; Bridges D; Blessing WW; Heath JW
    Brain Res; 1979 Sep; 173(1):65-78. PubMed ID: 487086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The retrograde axonal transport of nerve growth factor.
    Hendry IA; Stöckel K; Thoenen H; Iversen LL
    Brain Res; 1974 Mar; 68(1):103-21. PubMed ID: 4143411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction by reserpine of the accumulation of retrogradely transported [125I]nerve growth factor in sympathetic neurons.
    Johnson EM; Blumberg HM; Costrini NV; Bradshaw RA
    Brain Res; 1979 Dec; 178(2-3):389-401. PubMed ID: 92350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of neurotoxins to characterize the rates and subcellular distributions of axonally transported dopamine-beta-hydroxylase, tyrosine hydroxylase and norepinephrine in the rat brain.
    Levin BE
    Brain Res; 1979 May; 168(2):331-50. PubMed ID: 87244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of complement in degeneration of sympathetic nerves after administration of antiserum to dopamine beta-hydroxylase.
    Furness JB; Lewis SY; Rush R; Costa M; Geffen LB
    Brain Res; 1977 Nov; 136(1):67-75. PubMed ID: 589447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noradrenergic lesioning with an anti-dopamine beta-hydroxylase immunotoxin.
    Picklo MJ; Wiley RG; Lappi DA; Robertson D
    Brain Res; 1994 Dec; 666(2):195-200. PubMed ID: 7882029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-adrenergic modulation of synaptic transmission in rabbit pancreatic ganglia.
    Yi E; Love JA
    Auton Neurosci; 2005 Oct; 122(1-2):45-57. PubMed ID: 16126010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-dopamine beta-hydroxylase immunotoxin-induced sympathectomy in adult rats.
    Picklo MJ; Wiley RG; Lonce S; Lappi DA; Robertson D
    J Pharmacol Exp Ther; 1995 Nov; 275(2):1003-10. PubMed ID: 7473126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrograde axonal transport of beta-adrenoreceptors in rat brain: effect of reserpine.
    Levin BE
    Brain Res; 1984 May; 300(1):103-12. PubMed ID: 6203602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reserpine and the role of axonal transport in the independent regulation of pre- and postsynaptic beta-adrenoreceptors.
    Levin BE; Biegon A
    Brain Res; 1984 Oct; 311(1):39-50. PubMed ID: 6207896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.